Loading...
Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma
Epidermal growth factor receptor (EGFR) is frequently overexpressed in head and neck squamous cell carcinoma (HNSCC) and cetuximab, a monoclonal antibody targeting this receptor, is widely used to treat these patients. In the following investigation, we examined the role of SMAD4 down-regulation in...
Na minha lista:
| Udgivet i: | Cancer Biol Ther |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4623002/ https://ncbi.nlm.nih.gov/pubmed/26046389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2015.1056418 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|